Home Tags Pharmaceutical Industry

Tag: Pharmaceutical Industry

Evidence is mounting that psychedelic drugs can help treat diseases. Here are the most promising uses

There's been a resurgence of interest in psychedelic drugs' potential to treat conditions like depression. Research is beginning to lead to new treatments.
Novartis CEO Vas Narasimhan

Novartis is going after a $5 billion market with a new treatment for vision loss. That’s a big threat to Regeneron

Novartis' drug brolucizumab just showed that it wasn't any worse than Eylea, a drug from Regeneron, at treating an eye disease.

Trump’s new plan to drive down drug prices to fight ‘global freeloaders’ sounds exactly like what those ‘freeloaders’ ar...

President Donald Trump has decried "global freeloading" as driving up US drug prices, but his new plan looks similar to what other countries do.

The FDA just approved the first new flu treatment in nearly 20 years

The Food and Drug Administration just approved the first new flu treatment in nearly 20 years. The drug, Xofluza, can be used to treat the flu in people age 12 and older who have had symptoms for no more than two days.
Cigna CEO David Cordani speaking at CNBC’s Healthy Returns conference on March 28.

2 massive healthcare deals just got approved by the DOJ — and they will change healthcare as we know it

BI PRIME: Cigna + Express Scripts. Aetna + CVS Health. The mega-deals, once officially closed, will redraw the healthcare industry as we know it,  giving health plans a lot more control over who's paying for prescription drugs.
Chairman and CEO of Merck & Co., Kenneth Frazier, takes part in a panel discussion during the Clinton Global Initiative's annual meeting in New York, September 27, 2015.

The CEO of Merck has an ominous warning for the middlemen who stand between drug makers and patients

Merck CEO Kenneth Frazier thinks something has to change within the pharmaceutical industry to fix the issue of drug pricing. "I don't understand where we live in a world where 50% of the value goes to supply chain," Frazier said at an event at the Economic Club of New York.

Pfizer’s CEO is stepping down after 8 years — meet the man who will be replacing him

Pfizer CEO Ian Read is stepping down at the end of 2018, ending his eight-year tenure at the head of the pharma giant. He'll be replaced by Pfizer chief operating officer Albert Bourla in January 2019.
An illustration of a man suffering from a migraine.

Drugmakers are using an unusual tactic to compete in a new class of medication treating the 38 million Americans who have migraines

Until May, there weren't any FDA-approved drugs available for alleviating migraines, though other treatments — including Botox and anti-seizure medications — have been used. Pain relievers can also help treat some of the symptoms of migraines.
A human brain and its millions of small nerves

A new migraine medication that’s changing the way we treat a condition that affects 38 million Americans just got approved

The FDA just approved a new preventative migraine medication made by drug giant Eli Lilly. The drug, Emgality, is the third in a competitive new class of medication going after the 38 million Americans who have migraines.

A drug derived from marijuana has triggered the first federal shift on cannabis in half a century, and experts predict an avalanche effect

The nation's top drug regulator has officially changed how it regulates FDA-approved drugs that contain CBD, a marijuana compound, with the approval of the epilepsy drug Epidiolex. It's the first time in 46 years that the Drug Enforcement Administration has shifted its stance on cannabis.